Skip to content

Myriad Genetics MYGN Convertible Preferred Stock Authorized Shares

Convertible Preferred Stock Authorized Shares at other companies

Veracyte logo
VeracyteVCYT
5M0.0%
GeneDx Holdings logo
GeneDx HoldingsWGS
1M0.0%
Castle Biosciences logo
Castle BiosciencesCSTL
10M0.0%
Labcorp Holdings logo
Labcorp HoldingsLH
Guardant Health logo
Guardant HealthGH
Tempus AI, Inc. logo
Tempus AI, Inc.TEM

Other financials

Income statement

See full
Revenue$200.4M+2.3%
Gross profit$137.6M+2.5%
Operating income-$30.7M-5.9%
Net income-$34.1M-34,000%
EPS (diluted)-$0.36

Balance sheet

See full
Cash & equivalents$126.0M+24.8%
Total debt$211.5M+34.2%
Total equity$337.4M-52.1%
Total assets$673.7M-33.0%

Cash flow

See full
Operating cash flow-$15.7M+3.7%
CapEx$18.8M+181%
Free cash flow-$19.7M+65.1%

Valuation

See full
Market cap$512.85M+13.1%
Enterprise value$598.35M+17.3%
P/S0.6×+0.1×

Profitability

See full
Gross margin70%0.0pp
Operating margin-46.9%-88.3pp
Net margin-48.2%-72.9pp
FCF margin-17%

Returns & leverage

See full
Return on equity-76.7%-98.4pp
Debt / equity0.6×+0.4×
Current ratio2.4×+0.5×

Where this comes from

Reported directly by Myriad Genetics in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.

The official record: Myriad Genetics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Myriad Genetics's convertible preferred stock authorized shares.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Myriad Genetics's convertible preferred stock authorized shares?
Myriad Genetics (MYGN) reported convertible preferred stock authorized shares of 5M in Q1 2026.
How has Myriad Genetics's convertible preferred stock authorized shares changed year-over-year?
Myriad Genetics's convertible preferred stock authorized shares decreased by 0.0% year-over-year, from 5M to 5M.
What does convertible preferred stock authorized shares mean?
Maximum number of convertible preferred shares the company is authorized to issue under its corporate charter.